Introduction to Next-Generation Drug Development

Abstract

The process of finding new drugs is intricate and multidimensional, propelled by scientific advancements and cutting-edge technologies. In the fifteen years after Smith and O'Donnell, the Method of New Drug Development and Discovery . Second Edition (2005), the fields of drug discovery and development have seen tremendous changes. Developments within comprehension of biology in humans and illness have discovered new territory for substances to aim for, and this development of Knowledge has been quickened by the creation of innovative research instruments. Additionally, new platforms to effectively sort.Advances in understanding of human biology and disease have uncovered fresh territory for drugs to target, and this progression of knowledge has been accelerated by the invention of new investigational tools. Further, new platforms to efficiently sift through the drug candidates have made it easier to find that needle in the haystack, the drug that will treat a disease safely and effectively. What’s more, the processes of drug discovery and drug development, once separated in independent silos of sorts, have become increasingly integrated. No longer is the drug candidate handed off from drug inventor to drug developer like runners in a track relay meet. These changes in the drug discovery and development processes have reverberated throughout the biotech world, significantly impacting the scientific methodology employed for drug discovery initiatives as well as the institutional platforms underlying biomedical research.